HGH Injections For Sale

Things Secretly Increasing Your Prostate Cancer Risk, Says Expert Eat This Not That – Eat This, Not That

Prostate cancer is the number two cancer cause of death for men after lung cancer. There are about 268,490 new cases of prostate cancer and 34,500 deaths from prostate cancer per year. The American Cancer Society's recent estimates for prostate cancer in the United States suggest that about 1 man in 8 will be diagnosed with prostate cancer during his lifetime and about 1 man in 41 will die of prostate cancer. So it's important to know what the risk factors are for prostate cancer. Some are risk factors you cannot change. Some you can. Read on to learn about things increasing your prostate cancerand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

First the bad news: there are three main prostate cancer risk factors you cannot change:

But the good news is that there are many risk factors you can change, read on to find what you can do about them.

Obesity can cause prostate cancer by promoting inflammation throughout the body which may be associated either with initiation or progression of several cancers, including prostate cancer. Obesity increases the levels of hormones that can promote cancer growth. Hormones that promote prostate cancer growth insulin-like growth factor-1 (IGF-1). Obesity is also correlated with low physical activity.6254a4d1642c605c54bf1cab17d50f1e

Diet high in animal fat is a risk factor since it increases circulating levels of testosterone and other hormones that can promote cancer cell growth. Well done red meat can produce carcinogens call heterocyclic amines (HCAs). These are may cause prostate cancer.

Diets rich in calcium also increase the risk of prostate cancer although this may be associated with diets high in dairy products.

High level of testosterone, either naturally occurring or as a result of hormone therapy for conditions such as benign prostatic hyperplasia, may increase the risk of developing prostate cancer.

RELATED: Things That Put You at Risk for "Too High" Blood Sugar, Says Physician

Exposure to certain chemicals, such as cadmium, which is found in cigarettes, and pesticides.

Drinking too much alcohol: Drinking excessive amounts of alcohol can damage the DNA in cells, which can lead to the development of cancerous cells.

RELATED: Daily Habits You Must Follow If High Cholesterol Runs In Your Family

Smoking cigarettes: Smoking cigarettes has been linked to an increased risk of prostate cancer. This is due to the tobacco products damaging the DNA in cells and leading to cancerous growths.

If you are concerned about your risk of prostate cancer, talk to your doctor about ways to reduce your risk. These may include lifestyle changes, such as eating a healthy diet, avoiding excess alcohol, and getting regular exercise, as well as screenings for early detection.

Screening for the early detection of prostate cancer involves a digital rectal exam (DRE) and a prostate-specific antigen (PSA) blood test. The DRE allows the doctor to feel the prostate for any lumps or unusual growths. The PSA test measures the level of PSA in the blood, which can be elevated in men with prostate cancer.

If you have any of these risk factors for prostate cancer, talk to your doctor about whether screening is right for you. Early detection is key to successful treatment. And to protect your life and the lives of others, don't visit any of these 35 Places You're Most Likely to Catch COVID.

Gethin Williams MD Ph.D. is the Medical Director of Imaging & Interventional Specialists.

Gethin Williams, MD, Ph.D

Read this article:

Things Secretly Increasing Your Prostate Cancer Risk, Says Expert Eat This Not That - Eat This, Not That

Impact of the COVID-19 pandemic on therapy compliance and lifestyle factors of patients with growth hormone deficiency – DocWire News

This article was originally published here

Saudi Med J. 2022 Apr;43(4):418-422. doi: 10.15537/smj.2022.43.4.20210877.

ABSTRACT

OBJECTIVES: To recognize and assess treatment compliance in children and adolescents with growth hormone deficiency during the cronavirus disease-2019 (COVID-19) pandemic along with other lifestyle factors that might have been affected by the pandemic, such as diet, physical activity, sleep pattern, and screen time.

METHODS: This descriptive, cross-sectional study was carried out between March 2020-2021 at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Data were collected through clinical interview questions.

RESULTS: The total sample size was 130 patients, 54 (41.5%) of whom were males and 76 (58.5%) were females. The mean age of the patients was 12.563.44 years. Comparisons of before and during the COVID-19 pandemic revealed significant changes in growth hormone therapy compliance (p=0.007), dietary changes (p=0.002) with an increase in vegetables and fruit consumption, a significant decrease in physical activity time (p<0.001), an increase in sleep time (p<0.001), and screen time (p<0.001).

CONCLUSION: The COVID-19 crisis had an impact on growth hormone therapy compliance, with a significant impact on other lifestyle factors such as dietary habits, physical activity, sleep time, and leisure screen time.

PMID:35414621 | DOI:10.15537/smj.2022.43.4.20210877

See the original post here:

Impact of the COVID-19 pandemic on therapy compliance and lifestyle factors of patients with growth hormone deficiency - DocWire News

Somatostatin Analogues Drugs Market: Rise in the cases of carcinoid tumors and other hormonal diseases to drive the market – BioSpace

Albany NY, United States: Somatostatin is a protein that is naturally built in the body. The organs that usually contribute to the development of somatostatin are the hypothalamus, stomach, pancreas, and bowels. Somatostatin decelerates hormone production (including many gut hormones) and controls the release other hormones from the pancreas and the release growth hormones. Somatostatin analogues stop the production of too many hormones in the body and decelerate symptoms of carcinoid syndrome and slow down growth of tumors.

Read Report Overview - https://www.transparencymarketresearch.com/somatostatin-analogues-drugs-market.html

The global somatostatin analogues drugs market is primarily driven by a rise in the cases of carcinoid tumors and other hormonal diseases, increase in the diagnosis and treatment rate of carcinoid tumors, and rise in the incidence of hormonal disorders. Somatostatin analogues usually cause side effects such as loss of appetite, feeling sick, stomach pain, tiredness, diarrhea, and other disorders. The growth of the global somatostatin analogues drugs market could be hampered by the side effects caused by somatostatin analogues drugs, stringent drugs regulatory conditions, and intellectual property rights law. In addition, increase in the prices of raw materials and variations macroeconomic conditions are likely to restrain the growth of the global somatostatin analogues drugs market in near future. Nevertheless, mergers and acquisitions among major players, increase in R&D investments, and on-going product pipeline are estimated to provide attractive expansion opportunities to the global somatostatin analogues market during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58947

The global somatostatin analogues drugs market can be segmented based on product, application, route of administration, patient, distribution channel, and region. In terms of product, the global somatostatin analogues drugs market can be classified into octreotide, lanreotide, pasireotide, and others. Based on application, the global somatostatin analogues drugs market can be categorized into acromegaly, carcinoid syndrome, Cushing syndrome, neuroendocrine tumor, and others. In terms of route of administration, the global somatostatin analogues drugs market can be divided into enteral segment and parenteral segment. Based on patient, the global somatostatin analogues drugs market can be classified into adult and pediatric. In terms of distribution channel, the global somatostatin analogues drugs market can be divided into hospital pharmacies, retail pharmacies and Drugs stores, and others.

Request for Analysis of COVID-19 Impact on Somatostatin Analogues Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58947

Based on region, the global somatostatin analogues drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a prominent share of the global somatostatin analogues drugs market in 2017, owing to a highly developed pharmaceutical industry, high rate of diagnosis and treatment of carcinoid tumors and other hormonal disorders, well-established health care infrastructure, and presence of major players in the region. In Europe, Germany, France, and the U.K. accounted for a major share of the somatostatin analogues drugs market in 2017. The market in Italy and Spain is expected to expand at a significant growth rate during the forecast period. Highly developed health care industry, high rate of diagnosis and treatment of carcinoid tumors and other hormonal disorders, and participation of small companies in the market contributed to the key market share of Germany, France, and the U.K. in 2017.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=58947

China and Japan held a dominant share of the somatostatin analogues drugs market in Asia Pacific in 2017. The somatostatin analogues drugs market in India is estimated to expand at a significant CAGR in the near future, owing to the developing health care industry, presence of well-established domestic players, and intense competition between domestic and international players in the country. The somatostatin analogues drugs market in Latin America and Middle East & Africa is likely to be hampered by an underdeveloped health care industry and lack of awareness about somatostatin analogues drugs.

Pre Book Somatostatin Analogues Drugs Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=58947&ltype=S

Key companies operating the global somatostatin analogues drugs market are Novartis, Peptron, Chiasma, Inc, Ipsen Pharma, and others.

More Trending Reports by Transparency Market Research:

Pharma-grade Synthetic Camphor Market The global pharma-grade synthetic camphor market is majorly driven by the growing trend of self-medication amongst the patients across the world. This trend has picked up the momentum by the growing availability of over the counter drugs in the healthcare market. OTC decongestants are some of the most common examples of pharma-grade synthetic camphor that are available in the market. Easy access of these products is one of the major factors responsible for the growth of global pharma-grade synthetic camphor market in the forecast period of 2019 to 2027.

Uroflowmeter Market There is a high prevalence of chronic kidney disease (CKD) and rise in the rate of prostate gland enlargement among geriatric population. According to an NIH study, the overall prevalence of chronic kidney disease in general public is nearly 15%. High blood pressure and diabetes are primary causes of chronic kidney disease. Around 50% of people suffering from chronic kidney disease are either diabetic or have cardiovascular disease (CVD).

Blood Ketone Test Meter Market Ketones are produced by the body as an alternative source of energy to sugar. Ketone testing is a key part of Type 1 diabetes management, as it helps to prevent a dangerous short-term complication called diabetic ketoacidosis from occurring. The human body primarily runs on glucose. When there is a deficiency of glucose in the body, the body starts breaking down fats for energy. This breaking down of fats results in the creation of ketones.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Read this article:

Somatostatin Analogues Drugs Market: Rise in the cases of carcinoid tumors and other hormonal diseases to drive the market - BioSpace

Plants are ruled by their hormones – FreshPlaza.com

Hormones play a crucial role in human physiology and it is no different with plants.

Hormones are signaling molecules that in certain concentrations direct plant growth towards a specific direction, explains Jaques Landman, senior agronomist at Stoller South Africa.

We have patented a hormone cycle chart that illustrates the ratios of these different hormones during the various phenological stages of plant development, as well as the nutrient or elemental co-factors that are important for both hormone synthesis and the workings of different enzymes and plant physiological processes, specific to a crops growth stage.

Photos supplied by Stoller South Africa

Ten years ago, Stoller International, a market leader in plant physiological solutions, opened a subsidiary in South Africa with its head office in Nelspruit, Mpumalanga, and a current presence across the country. The focus crops of Stoller South Africa are citrus, macadamia, pome and stone fruits, grapes, potatoes and vegetables, as well as grains like soybeans, wheat and maize.

Stoller Integrated SolutionsJaques adds that during physiological processes commonly affected by various stress factors during the crop growth cycle, managing plant hormones can play a valuable ameliorative role in the form of Stoller Integrated Solutions (SIS), predominantly applied as foliar applications.

These SISs are comprised of uniquely formulated products, which target very specific physiological processes within a plant. Stoller International has many liquid products that contain specific ratios and concentrations of plant growth hormones like Stimulate, X-Cyte, and so forth, he says.

These products can be applied through fertigation systems, through normal spray equipment and can be mixed with other agrochemicals, but the company advises growers to consult with an agronomist to assist with the mixability.

Right: Root Feed 2 by Stoller

The advantage of managing plant physiological processes with hormones include more UV resistance, higher stability and concentration consistency.

Stimulate, a product in the process of being registered in South Africa, enhances plant growth, promotes vigorous early root growth and assists the plant in maintaining a proper hormone balance through its active ingredients of auxin, cytokinin and gibberellic acid.

Hormonal balance affected by many variablesNot all products are plant hormone based, as the company strives to develop products that holistically address key physiological processes. A plants hormonal balance is unpredictable and variable, depending on aspects such as climate, crop cultivars, soil type, soil condition and fertility, agronomic practices and, of course, the level of pest activity.

Each product is formulated and applied at key plant physiological stages to stimulate a response from the plant to rectify plant hormonal balance, nutrient status and/or stress event. We use our patented plant hormonal cycle, plant physiology knowledge and the crops growth cycle to determine the optimal Stoller solution.

Jaques notes that a farmer definitely wants a healthy leaf canopy to support the plants energy needs via photosynthesis, but too much vegetative growth impinges on reproductive growth which equates to lower yields and ultimately lower profitability.

An Orri orchard in Mpumalanga Province, treated with Stoller Root Feed 2, increased in root mass and developed more stem internodes

TrialsIn Chihuahua, Mexico, an avocado orchard in which the Stollers Root Feed II was applied resulted in a 15% greater root biomass and a resultant 7% increase in production.

Stoller South Africas macadamia trials were launched with the Stoller Integrated Solutions approach containing Root Feed II in Barberton in 2017 and was concluded during May 2020. Over the four seasons, data showed a consistent increase in yield and sound kernel recovery, with a resultant rise in profits per hectare.

In a citrus trial outside Nelspruit, eight applications of Stollers Root Feed II led to a significant increase in root mass of young Orri trees and more internodes per stem.

We pride ourselves on having supported scientific statistical data behind our trials, Jaques concludes.

For more information:Jaques LandmanStoller South AfricaTel: +27 13 007 1678Cell: +27 72 355 4433Email: jlandman@stoller-africa.comhttps://stollersouthafrica.co.za/

Plants are ruled by their hormones - FreshPlaza.com

Specialty Pharmaceuticals Market Size Research 2022 Global Share Analysis by Regional Segments, Sales and Revenue, Demand Status, Upcoming Trends,…

Rising spending on pharmaceuticals and growing product innovation to develop novel specialty drugs are the major factors driving the growthof Global Specialty Pharmaceuticals Market.

Scope ofSpecialty Pharmaceuticals Market Report-

Specialty pharmaceuticals are also referred as specialty drugs that are classified as high-cost, high complexity and high touch. These drugs derived from living cells that are injectable or infused through oral, parenteral and transdermal medications. In fact, specialty pharmaceuticals have rapidly growing share of total drug expenditures by public and private health plans. These drugs are mainly used to treat serious, chronic or life-threatening conditions such as cancer, growth hormone deficiency, rheumatoid arthritis and multiple sclerosis. Specialty drugs are more expensive than traditional drugs. These pharmaceuticals consist of many of the latest advance treatments for a range of serious conditions like rheumatoid arthritis, HIV and cancer. Many specialty pharmaceuticals are possible to improve both life expectancy and quality of life for patients.

Download Free Exclusive Sample (200 Pages PDF) Report @ :

https://brandessenceresearch.com/requestSample/PostId/1097

Specialty Pharmaceuticals Companies:

Global Specialty Pharmaceutical market report covers prominent players,

Pfizer Inc.

Amgen Inc.

AstraZeneca

Teva Pharmaceutical Industries Ltd.

Otsuka America Pharmaceutical, Inc

rEVO Biologics, Inc

AbbVie Inc.

Gilead

Janssen Global Services, LLC

Others.

Global Specialty Pharmaceuticals MarketSegmentation:-By Therapeutic Area:

Oncology

Inflammatory conditions

Multiple sclerosis

Growth hormone

Other disease conditions

By Route of Administration:

Oral

Parenteral

Transdermal

By Distribution Channel:

Hospitals

Retail Pharmacies

Specialty Pharmacies

Mail Order

Global Specialty Pharmaceuticals MarketDynamics:-

Rising spending on pharmaceutical and launch of high number of novel specialty drugs are the major factors driving the market growth. According to National Conference of State Legislatures, as of 2015, about 36% of total pharmaceutical spending in the commercial market was devoted to specialty medications.

Global Specialty Pharmaceuticals MarketRegional Analysis

North America is expected to dominate the global specialty pharmaceuticals market with highest shares due to the heavy investments in R&D initiatives, technological expansions and integration of pioneering technologies, presence of major players in and occurrence of lifestyle related diseases in this region. In 2017, a wide variety of drug therapies to improve the health of the American public were approved by The Center for Drug Evaluation and Research (CDER). As per a study, the research-based pharmaceutical industry currently spends over USD 149.8 billion on R&D per year. In addition, due to fast development of new pharmaceutical industries, major merges and acquisitions among pharmacies, high buying power and reimbursement for the specialty pharmaceuticals are some of the major factors fostering the growth of specialty pharmaceutical market in this region during the forecast period.

Asia Pacific market is expected to witness a strong growth rate majorly due high population growth rate, growing prevalence of chronic diseases and rising adoption of advanced technologies in this region. As per World Health Organisation, Chronic disease risks and deaths are increasing rapidly, especially in low and middle-income countries. According to WHO, almost 23.6 million people will die from CVDs, mainly from heart disease and stroke by 2030.

Key Benefits for GlobalSpecialty Pharmaceuticals MarketReport

Global specialty pharmaceuticals market report covers in depth historical and forecast analysis.

Global specialty pharmaceuticals market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global specialty pharmaceuticals market report helps to identify opportunities in market place.

Global specialty pharmaceuticals market report covers extensive analysis of emerging trends and competitive landscape.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact No.: +91 7447409162, +44-2038074155, 1-888-853-7040

Email: [emailprotected]

Start on the road to a healthier you with the 21-Day Intermittent Fasting Challenge for only $19 – WSLS 10

Hows that New Years Resolution to lose weight coming along? We get it. Most of us have been there. Shedding the pounds while keeping yourself happy and healthy is no easy task. Sure there are alternatives bariatric surgery or laser treatments to name a couple. But why not try a method that does not require going under the knife and is inexpensive? The 21 Day Intermittent Fasting Challenge could be what you need to succeed in your weight loss journey.

So what exactly is Intermittent Fasting? Essentially its just what the name implies. Its an eating pattern that cycles between periods of fasting and eating. It doesnt specify which foods you should eat but rather when you should eat them. Not only can it help you lose weight and visceral fat, but it has also been known to reduce the blood levels of insulin in your body while increasing the human growth hormone levels. It has been shown to improve blood pressure and triglycerides, reduce the risk of cancer, and help to prevent Alzheimers, among other benefits.

This 21 Day Intermittent Fasting Challenge gets you started on the road to a healthier you. You will receive a meal plan that includes 2 meals and one snack daily, plus an overview of what food you can and should not eat. You will learn about potential side effects and how to avoid them, plus be introduced to a variety of fasting methods. You can customize your intake depending on your diet of choice there are Keto, vegan, Paleo, vegetarian, and Vegan Keto plan options available.

Best of all, you will not be doing this alone. Once you sign on, you will become part of an exclusive community of like-minded people from all around the world with whom you will be able to share your successes, ask questions, or look for guidance.

So stop procrastinating. By doing this challenge, and pairing it with a good exercise program, you could be very pleasantly surprised by the results. Get lifetime access to the 21 Day Intermittent Fasting Challenge for only $19, an 80% discount off the regular suggested retail price.

Prices subject to change.

Continue reading here:

Start on the road to a healthier you with the 21-Day Intermittent Fasting Challenge for only $19 - WSLS 10

Protein Therapeutics Market Report 2023 Market SWOT Analysis, Key Indicators, Forecast 2027. – Digital Journal

Market Overview

The Global Protein Therapeutics Market is expected to cross USD 290,691.88 Million by 2027 at a CAGR of 6.86%.

Market Dynamics

One of the most important classes of pharmaceuticals is therapeutic protein therapies. These medications are used to treat and manage a variety of conditions, including cancer and infectious infections. Protein therapeutic medicines offer a great deal of promise to improve human health, thus demand for these treatments is expected to skyrocket in the future. During the projected period, the increased prevalence of chronic diseases such as diabetes is expected to have an impact on the protein therapies markets growth. Rapid technological breakthroughs in the field of protein therapies are expected to have a beneficial impact on demand. During the forecast period, increased awareness of protein therapies is expected to fuel the global protein therapeutics markets growth. Protein therapeutics market growth is expected to be boosted in the near future by the increased use of plasma-derived medicines for the treatment of chronic diseases. Increased government measures to strengthen the healthcare sector are projected to create favourable conditions for the protein therapies market to grow.

During the projected period, however, the tight regulatory environment governing product approval is expected to restrain the growth of the protein therapies market. Protein treatments market expansion is projected to be constrained by their high cost.

Sample Report: https://www.marketresearchfuture.com/sample_request/10142

Segmental Analysis

The market for protein therapeutics has been divided into three categories: type, application, and end user.

Monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormone, follicle-stimulating hormone, and others are among the products available. Because of the rising prevalence of diabetes around the world, the insulin segment is the fastest-growing.

The worldwide protein therapies market has been divided into cancer, metabolic diseases, immunologic disorders, haematological disorders, and others based on application. Because of the increased frequency of cancer around the world, the cancer segment accounts for a substantial portion of the worldwide protein therapies market.

The global protein therapies market has been divided into hospitals and clinics, specialty centres, and others based on the end user. During the projected period, the hospitals and clinics segment is expected to develop due to an increase in hospital admissions and the increased prevalence of chronic diseases.

Regional Overview

During the review period, the Americas was the largest regional market. The demand for therapeutic proteins is expanding as a result of increased government initiatives and growing concerns about healthcare workers health and safety. Moreover, one of the primary factors driving the protein therapies market over the forecast period is the increased prevalence of cancer. With such a big patient population, the global protein therapies market is expected to increase significantly in the near future.

During the forecast period, the western European healthcare market, which includes Germany, the United Kingdom, France, and Italy, is expected to see an increase in healthcare expenditure, as well as an increase in cases of rheumatoid arthritis, multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy, resulting in the growth of the protein therapeutics market. During the forecast period, it is expected to enhance the growth of the protein therapies market.

The fastest-growing geographical market is Asia-Pacific. Emerging market participants in previously untouched regions, increased R&D in the protein therapeutics segment, the governments increased focus on immunisation to avoid various diseases, and a large target population are all factors impacting market expansion. One of the primary factors driving the regions protein therapies market growth is the expanding elderly population.

The expansion of the protein therapeutics market in the Middle East and Africa is likely to be fueled by government efforts and increased investments in the healthcare sector in the UAE and South Africa.

Access Report Details @ https://www.marketresearchfuture.com/reports/protein-therapeutics-market-10142

Competitive Dynamics

The notable players of the market are Abbott Laboratories (US), Amgen Inc. (US), Baxter International Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson (US), Merck & Co., Inc. (US), Novo Nordisk A/S (Denmark), CSL Behring (US), Bristol Myers Squibb Co. (US), Pfizer Inc. (US), Sanofi (France), and Biogen, Inc. (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Get More Related Reports:

https://www.marketresearchfuture.com/reports/women-healthcare-market-3121

https://www.marketresearchfuture.com/reports/big-data-pharmaceutical-advertising-market-1014

https://www.marketresearchfuture.com/reports/enema-based-products-market-4370

https://www.marketresearchfuture.com/reports/dermabrasion-market-4702

https://www.marketresearchfuture.com/reports/cancer-biologic-therapy-market-566

Contact:

Market Research Future

99 Hudson Street,5Th Floor

New York, New York 10013

United States of America

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)

Email: [emailprotected]

Excerpt from:

Protein Therapeutics Market Report 2023 Market SWOT Analysis, Key Indicators, Forecast 2027. - Digital Journal

Grieving mom wants true account of how son died training as SEAL – centraljersey.com

Editors note: The author of this Your Turn guest column is Regina Mullen, whose son, Kyle Mullen, 24, a native of Manalapan and a graduate of Manalapan High School, died earlier this year while he was training to become a U.S. Navy SEAL. Regina Mullen is seeking a full account of what happened to her son.

By Regina Mullen

Democracy and freedom are founded on an informed public. I would like the public to be made aware of the U.S. Navy SEALs medical negligence.

Unfortunately, due to my son Kyle Mullens passing, I am learning of other atrocities and cover-ups that have been going on for years.

The American public and the government should care about the fate of men who courageously risk their lives to defend this great nation. The public needs to demand an independent investigation by the government and report the findings to the congressional committee that oversees the military.

Immunity should be offered in order to induce SEAL cooperation and the investigation would be a means for truth and to hold those responsible accountable for their actions.

Substantial recommendations to the U.S. Department of Defense and to Congress should be submitted for consequences and reform.

Please continue reading this column to see a letter Congressman Andy Kim (D-NJ), who is a member of the House of Representatives Armed Services Committee, has sent to Sean ODonnell, the acting inspector general of the U.S. Department of Defense, requesting an immediate inspector general investigation into the death of my son, a Navy SEAL candidate who died hours after completing Hell Week.

My son was found on the barracks floor by a 19-year-old non-medical sailor. Kyle did not die in a hospital as the media continually states inaccurately.

Another SEAL candidate was sent to the hospital that day, Feb. 4, 2022, in critical condition. That individual was intubated and treated for severe pneumonia, which is what I believe Kyle also had.

The Navy to this date has yet to reveal Kyles autopsy results, which is another concerning matter.

In his letter to ODonnell, Congressman Kim states, As a member of the House Armed Services Committee, I write to you today out of deep concern and sadness over the tragic death of New Jersey resident and Navy SEAL candidate Kyle Mullen.

Kyle was only 24 years old when he died waiting for medical attention in San Diego justhours after finishing the Hell Week portion of the SEAL selection process.

I strongly urge and respectfully request that you immediately initiate a full and thorough investigation into the incident involving Kyle Mullen and the circumstances that led to his death.

Its my understanding there were multiple warning signs, but candidate Mullen was notoffered comprehensive nor consistent medical treatment.

I am deeply concerned by allegations that multiple calls for assistance went unanswered and that officers and instructors may have encouraged and facilitated the use of steroids and Human Growth Hormone for recovery, Kim wrote.

Kyle, his family, friends and community deserve to know the truth about what happened on that day. The entire country deserves to know and trust that we treat our men and women in uniform, including those that are vying for elite positions to serve their country, with the utmost professionalism, dignity, decency and highest quality of care at all times. Anything less is unacceptable.

While I am aware there is a Navy investigation underway into Kyles death, I feel it entirely appropriate to launch an independent Inspector General investigation as well and I encourage you to leave no stone unturned.

Steps should be taken to ensure there is no retaliation against anyone for participating in the investigation. Moreover, no officers nor instructors, regardless of rank, ought to be shielded from accountability or allowed to avoid investigation through assignment changes or retirement.

I also ask that you share any and all outcomes of that investigation with Kyles family and the public so there is accountability for any individuals that bear responsibility. It goes without saying that a single death during a training exercise is one too many and that our military families deserve better, Kim wrote to ODonnell.

As things stand now, the SEALs investigate themselves. This is absurd. There is no doubt that without Congresss involvement, both through oversight and administering the investigation itself, there will be no chance of reform.

I am encouraging members of the public and all military personnel those who are currently serving and those who are veterans to call, write and/or email members of Congress, senators, etc., to not only provide their own stories, but to demand an immediate investigation. I hope we can help to save young mens lives in the future.

Regina Mullen is the mother of Kyle Mullen.

View original post here:

Grieving mom wants true account of how son died training as SEAL - centraljersey.com

Healthy Month of Ramadan: Benefits of fasting – Scoop Empire

The holy month of Ramadan is all about fasting and endurance of everyday life while abstaining from all foods and drinks. There are so many reasons why Muslims fast during Ramadan. But other than the obvious religious and spiritual reasons, fasting was always attributed to many health benefits. In this new day and age, we have science-backed research to prove said health benefits. But, what are they? And how does fasting aid them?

Weight loss, delay aging, and muscle gain are all goals for all of us. Who doesnt want the perfect build or waist measurements! Well, all of those come easily during Ramdan since fasting helps with all of them. When it comes to weight loss, research has found that whole-day fasting could reduce body weight by up to 9% and significantly decrease body fat over 1224 weeks, it was also found that it is more effective than calorie restriction, especially at increasing fat loss while simultaneously preserving muscle tissue which is a hard balance to achieve, gym-goers know that for a fact. This is also connected to increasing HGH or human growth hormone which leads to growth, metabolism, weight loss, and muscle strength. A study in 11 healthy adults showed that fasting for 24 hours significantly increased levels of HGH. Which will automatically help with muscle growth and complete rejuvenation of the body.Delaying aging however is still in the works to be proven. Studies on rats showed that fasting every other day increased their longevity in living by 83% which is very promising if proven generally.

Fasting does wonders to our internal systems and metabolism, so much so that it affects every bodily system altogether. When it comes to the Cardiovascular System it is a common fact that a healthy balanced diet helps reduce the risk of getting heart disease. A study showed that eight weeks of alternate-day fasting reduced levels of bad LDL cholesterol and blood triglycerides by 25% and 32%. Another study showed that 110 obese adults showed that fasting for three weeks under medical supervision significantly decreased blood pressure, as well as levels of blood triglycerides, total cholesterol, and bad LDL cholesterol. All of these decreased numbers are vital to keeping our hearts and vascular system healthy and fasting is key to achieving that.

Another major system that scientists are trying to connect improvement to fasting is the nervous system and mental health. And while research on this particular system is limited to animal testing, a study on mice found that practicing intermittent fasting for 11 months improved both brain function and brain structure up to the point where it can prevent neurodegenerative disorders and protect against conditions such as Alzheimers disease and Parkinsons.

All and all there is still so much research to be conducted in many fields and ways to get to the bottom of this. One thing is for sure, no matter what you fast for whether its health or religion. The benefits are undeniable. And depending on the type of fasting you choose which there are many youll definitely get the desired results if you can just keep on it and endure it for a set amount of time.

Excerpt from:

Healthy Month of Ramadan: Benefits of fasting - Scoop Empire

Prader-Willi Syndrome Market to Exhibit Healthy Growth Rate till 2032, Investigates DelveInsight | Key Companies Millendo Therapeutics, Levo…

DelveInsights Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prader-Willi Syndrome Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Prader-Willi Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Prader-Willi Syndrome: An Overview

According to US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity.

Although considered a rare disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.

Prader-Willi Syndrome Market Key Facts

As per Foundation for Prader-Willi Syndrome (PWS) Research, the disease occurs in approximately one out of every 15,000 births

It affects males and females with equal frequency and affects all races and ethnicities.

The estimates place the incidence between 1 in 10,000-30,000 individuals in the general population, while as per Adult Prader-Willi Syndrome: An Update on Management by Luk Ho-Ming, the incidence is about 1 in 15,00025,000 live births.

According to DelveInsights estimation, the total prevalent cases of Prader Willi syndrome (PWS) were found to be approx. 47,000 in the 7 Major Markets in the year 2017.

Prader-Willi Syndrome Market

The Prader-Willi Syndrome Market Size is expected to experience a positive shift during the study period owing to the launch of upcoming therapies. The therapies under development are focused on novel approaches that will improve the disease condition.

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Prader-Willi Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Prader-Willi Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Prader-Willi Syndrome Epidemiology

The epidemiology section covers insights into the historical and current Prader-Willi Syndrome patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Prader-Willi Syndrome Epidemiology Subtype Segmentation

Prevalent cases of Prader Willi Syndrome

Diagnosed cases of PWS

Prader Willi Syndrome (PWS) cases by Mutation types

Prader Willi Syndrome (PWS) associated clinical Manifestation

Prader-Willi Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to get launched in the market during the study period. The analysis covers Prader-Willi Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.

Reports Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Prader-Willi Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in various stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report https://www.delveinsight.com/sample-request/prader-willi-syndrome-market

Prader-Willi Syndrome Therapeutics Analysis

Currently, there is no cure for PWS. The lives of individuals with PWS can be improved with an early diagnosis and careful management of symptoms but more effective therapies are needed. The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. Growth hormone deficiency is present in almost all children and many adults with PWS. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome.

Some of the key companies in the Prader-Willi Syndrome Market include:

Millendo Therapeutics

Levo Therapeutics

Harmony Biosciences

Soleno Therapeutics

And many more.

Prader-Willi Syndrome Therapies covered in the report include:

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies https://www.delveinsight.com/sample-request/prader-willi-syndrome-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary

3. Prader-Willi Syndrome Competitive Intelligence Analysis

4. Prader-Willi Syndrome Market Overview at a Glance

5. Prader-Willi Syndrome Disease Background and Overview

6. Prader-Willi Syndrome Patient Journey

7. Prader-Willi Syndrome Epidemiology and Patient Population

8. Prader-Willi Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Prader-Willi Syndrome Unmet Needs

10. Key Endpoints of Prader-Willi Syndrome Treatment

11. Prader-Willi Syndrome Marketed Products

12. Prader-Willi Syndrome Emerging Therapies

13. Prader-Willi Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Prader-Willi Syndrome Market Outlook (7 major markets)

16. Prader-Willi Syndrome Access and Reimbursement Overview

17. KOL Views on the Prader-Willi Syndrome Market.

18. Prader-Willi Syndrome Market Drivers

19. Prader-Willi Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report https://www.delveinsight.com/sample-request/prader-willi-syndrome-market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

Metrorrhagia Market

DelveInsights Metrorrhagia Market report delivers an in-depth understanding of the historical and forecasted epidemiology, the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.

Media ContactCompany Name: DelveInsight Business ResearchContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/

See the original post:

Prader-Willi Syndrome Market to Exhibit Healthy Growth Rate till 2032, Investigates DelveInsight | Key Companies Millendo Therapeutics, Levo...